Epstein Secrets

ms in the case, cited as Jane Does, say the necessary remedy is for Epstein to face what they say are long overdue charges in Florida. "To be sure, Jane Doe 1 and 2 very much appreciate the laudable efforts of the diligent prosecutors in New York," their lawyers wrote. "But those New York charges, importan

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

fore-we-do-something-bad claim that deserves no credence from the Court," wrote Edwards and his co-counsel on behalf of the two women, identified as Jane Doe 1 and Jane Doe 2. They also pointed out that the prosecutors weren't asserting the alleged "risk" to some victims outweighs obtaining justice for the

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been

fore-we-do-something-bad claim that deserves no credence from the Court," wrote Edwards and his co-counsel on behalf of the two women, identified as Jane Doe 1 and Jane Doe 2. They also pointed out that the prosecutors weren't asserting the alleged "risk" to some victims outweighs obtaining justice for the

regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been